Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $329.96 million. The enterprise value is $235.29 million.
Important Dates
The next confirmed earnings date is Wednesday, February 26, 2025, before market open.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 204.94 million shares outstanding. The number of shares has increased by 203.71% in one year.
| Current Share Class | 204.94M |
| Shares Outstanding | 204.94M |
| Shares Change (YoY) | +203.71% |
| Shares Change (QoQ) | +15.03% |
| Owned by Insiders (%) | 13.57% |
| Owned by Institutions (%) | 59.44% |
| Float | 128.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 38.27 |
| Forward PS | 47.46 |
| PB Ratio | 3.72 |
| P/TBV Ratio | 3.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 23.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.51, with a Debt / Equity ratio of 0.71.
| Current Ratio | 5.51 |
| Quick Ratio | 5.38 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -104.02 |
Financial Efficiency
Return on equity (ROE) is -114.77% and return on invested capital (ROIC) is -63.36%.
| Return on Equity (ROE) | -114.77% |
| Return on Assets (ROA) | -27.42% |
| Return on Invested Capital (ROIC) | -63.36% |
| Return on Capital Employed (ROCE) | -54.67% |
| Revenue Per Employee | $190,673 |
| Profits Per Employee | -$437,923 |
| Employee Count | 52 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.12% in the last 52 weeks. The beta is 0.90, so TSHA's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -25.12% |
| 50-Day Moving Average | 1.76 |
| 200-Day Moving Average | 2.24 |
| Relative Strength Index (RSI) | 46.14 |
| Average Volume (20 Days) | 2,114,272 |
Short Selling Information
The latest short interest is 24.08 million, so 11.75% of the outstanding shares have been sold short.
| Short Interest | 24.08M |
| Short Previous Month | 23.95M |
| Short % of Shares Out | 11.75% |
| Short % of Float | 18.74% |
| Short Ratio (days to cover) | 11.07 |
Income Statement
In the last 12 months, TSHA had revenue of $9.92 million and -$22.77 million in losses. Loss per share was -$0.10.
| Revenue | 9.92M |
| Gross Profit | 9.92M |
| Operating Income | -82.49M |
| Pretax Income | -118.01M |
| Net Income | -22.77M |
| EBITDA | -81.18M |
| EBIT | -82.49M |
| Loss Per Share | -$0.10 |
Full Income StatementBalance Sheet
The company has $157.69 million in cash and $63.02 million in debt, giving a net cash position of $94.67 million or $0.46 per share.
| Cash & Cash Equivalents | 157.69M |
| Total Debt | 63.02M |
| Net Cash | 94.67M |
| Net Cash Per Share | $0.46 |
| Equity (Book Value) | 88.80M |
| Book Value Per Share | 0.43 |
| Working Capital | 132.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$79.03 million and capital expenditures -$393,000, giving a free cash flow of -$79.43 million.
| Operating Cash Flow | -79.03M |
| Capital Expenditures | -393,000 |
| Free Cash Flow | -79.43M |
| FCF Per Share | -$0.39 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -831.93% and -229.67%.
| Gross Margin | 100.00% |
| Operating Margin | -831.93% |
| Pretax Margin | -229.67% |
| Profit Margin | -229.67% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -203.71% |
| Shareholder Yield | -203.71% |
| Earnings Yield | -6.90% |
| FCF Yield | -24.07% |
Analyst Forecast
The average price target for TSHA is $6.63, which is 311.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.63 |
| Price Target Difference | 311.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 79.06% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of -2.23 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.23 |
| Piotroski F-Score | 1 |